Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|17|18|1808-1817
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.17, Iss.18, 2011-06, pp. : 1808-1817
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Etomoxir appears `to have promise as a novel form of therapy for heart failure'
Inpharma, Vol. 1, Iss. 1264, 2000-01 ,pp. :
Metabolic Therapy of Heart Failure
Current Pharmaceutical Design, Vol. 14, Iss. 25, 2008-09 ,pp. :
The Developing Role of Neuregulin1 In Cardiac Regenerative Stem Cell Therapy
Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. :